Glenmark Pharmaceuticals has informed that it enclosed a media release dated September 30, 2021 titled ‘Glenmark receives marketing approval for Ryaltris, an innovative combination nasal spray, in 13 countries across the EU and UK’.
The above information is a part of company’s filings submitted to BSE.